Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.

While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result ...

WASHINGTON, DC - OCTOBER 06: Activists protest the price of prescription drug costs in front of the ... [+] U.S. Department of Health and Human Services (HHS) building Your father’s rheumatoid ...

Pharmacy benefits managers, or PBMs, are meant to act as a middleman between drug manufacturers and insurance companies to lower drug prices. But some lawmakers have questioned if thats really the ...

Colorado’s spending on highly effective but costly weight-loss drugs for state workers more than quadrupled from 2023 to 2024 — and costs have been doubling every six months. Now, the state ...